Escitalopram in Obsessive-Compulsive Disorder:Response of Symptom Dimensions to Pharmacotherapy
Authors:
- Dan J. SteinDSDan J. Stein
- Paul D. CareyPCPaul D. Carey
- Christine LochnerCLChristine Lochner
- Soraya SeedatSSSoraya Seedat
- Naomi FinebergNFNaomi Fineberg
- Elisabeth Wreford AndersenEAElisabeth Wreford Andersen
- 1 June 2008
- journal article
- research article
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 13 (6) , 492-498
Abstract
Introduction:: There is a substantial body of evidence that obsessive-compulsive disorder (OCD) symptoms can be grouped into a series of discrete dimensions, and some evidence that not all OCD symptom dimensions respond equally well to pharmacologic or psychotherapeutic intervention. The response of OCD symptom dimensions to 12 weeks of treatment with escitalopram or placebo was investigated.Methods:: Data from a randomized, double-blind, placebo-controlled study of escitalopram in 466 adults with OCD were analyzed. Exploratory factor analysis of individual items of the Yale-Brown Obsessive-Compulsive Scale checklist was performed and subscale scores based on the extracted factors were determined. Analyses of covariance were undertaken to determine whether inclusion of each subscale score in these models impacted on the efficacy of escitalopram versus placebo.Results:: Exploratory factor analysis of individual Yale-Brown Obsessive-Compulsive Scale items yielded 5 factors (contamination/cleaning, harm/checking, hoarding/symmetry, religious/sexual, and somatic/hypochondriacal). Analyses of covariance including all the subscales demonstrated that escitalopram was more effective than placebo. There was a significant interaction for the hoarding/symmetry factor, which was associated with a poor treatment response.Conclusion:: Escitalopram shows good efficacy across the range of OCD symptom dimensions. Nevertheless, hoarding/symmetry was associated with a poorer treatment response. Hoarding/symmetry may be particularly characteristic of an early-onset group of OCD patients, with the involvement of neurotransmitters other than serotonin. Further work is needed to delineate fully the subtypes of OCD, and their correlates with underlying psychobiology and treatment responsivity.Keywords
This publication has 43 references indexed in Scilit:
- Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive‐compulsive disorder with compulsive hoardingAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Paroxetine treatment of compulsive hoardingJournal of Psychiatric Research, 2007
- Hoarding in Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry, 2005
- Efficacy of escitalopram in patients with severe depression: a pooled analysisInternational Journal Of Clinical Practice, 2005
- Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose studyDepression and Anxiety, 2004
- Cerebral Glucose Metabolism in Obsessive-Compulsive HoardingAmerican Journal of Psychiatry, 2004
- Relation of factor‐analyzed symptom dimensions of obsessive‐compulsive disorder to personality disordersActa Psychiatrica Scandinavica, 2000
- Hoarding in Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry, 1999
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A Warning to Fathers, Teachers, and Young Men, in relation to a fruitful Cause of Insanity, and other serious Disorders of YouthAmerican Journal of Psychiatry, 1861